라니티딘

Provisional sale of ranitidine gastrointestinal drugsbrProvisional discontinuation of the drug for the treatment of gastric ulcers with ranitidine was detected.brbrNegative carcinogen component residues, etc.brThe Korean Medical Association noted that carcinogens are detected in some ranitidine-based gastrointestinal drugs, such as xanthac, and are solely responsible for the Ministry of Food and Drug Safety and pharmaceutical companies.brbrDiscussion on how to reduce ranitidine recovery and pharmaceutical marginsbr[Medical Newspaper, Daily Press Reporter]brbrbrbrbr[Graphics Sticker] Detection of gastrointestinal ingredient ranitidine carcinogenbrThe Seoul Metropolitan Food and Drug Administration has collected and tested ranitidine-based pharmaceuticals used as the main ingredients for the treatment of gastric ulcers and reflux esophagitis.brbrbrbrbrbrbrbr